乳腺癌骨转移的相关研究进展

彤 齐(青海大学附属医院乳腺甲状腺外科，中国)
宇飞 王(青海大学附属医院乳腺甲状腺外科，中国)
晓武 王(青海大学附属医院乳腺甲状腺外科，中国)

摘要

乳腺癌是女性常见的恶性肿瘤之一，从临床表现上讲，乳腺癌会优先转移到骨骼，显著影响了乳腺癌患者的生活质量和生存率，加重了社会经济负担。乳腺癌骨转移的转移治疗是乳腺癌治疗过程中一个具有挑战性的方面，在过去的几年里，越来越多的研究报道了促进乳腺癌细胞原发性和转移部位骨转移的因素。识别与骨转移相关的因素有助于早期识别骨转移趋势，针对这些因素并最大限度地减少对骨骼的副作用仍有待进一步探索。因此，论文就目前乳腺癌骨转移领域的研究现状作一综述。

关键词

乳腺癌；骨转移；治疗；综述

参考

中国抗癌协会乳腺癌专业委员会,中华医学会肿瘤学分会乳腺肿瘤学组.中国抗癌协会乳腺癌诊治指南与规范(2024年版)[J].中国癌症杂志,2023,33(12):1092-1187.

Tahara R K, Brewer T M, Theriault R L, et al. Bone Metastasis of Breast Cancer[J]. Adv Exp Med Biol, 2019,1152:105-129.

Soni S, Torvund M, Mandal C C. Molecular insights into the interplay between adiposity, breast cancer and bone metastasis[J]. Clin Exp Metastasis, 2021,38(2):119-138.

Nicolini A, Ferrari P, Duffy M J. Prognostic and predictive biomarkers in breast cancer: Past, present and future[J]. Semin Cancer Biol, 2018,52(Pt1):56-73.

Zhang C, Sun C, Zhao Y, et al. Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021[J]. Int J Mol Sci, 2022,23(19).

Wang S, Wu W, Lin X, et al. Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions[J]. Cell Biosci, 2023,13(1):224.

Holen I, Lefley D V, Francis S E, et al. IL-1 drives breast cancer growth and bone metastasis in vivo[J]. Oncotarget, 2016,7(46):75571-75584.

Haider M T, Ridlmaier N, Smit D J, et al. Interleukins as Mediators of the Tumor Cell-Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis[J]. Int J Mol Sci, 2021,22(6).

Jafari S H, Saadatpour Z, Salmaninejad A, et al. Breast cancer diagnosis: Imaging techniques and biochemical markers[J]. J Cell Physiol, 2018,233(7):5200-5213.

Karatas M, Zengel B, Durusoy R, et al. Clinicopathologic features of single bone metastasis in breast cancer[J]. Medicine (Baltimore), 2021,100(1):e24164.

Coleman R E, Smith P, Rubens R D. Clinical course and prognostic factors following bone recurrence from breast cancer[J]. Br J Cancer, 1998,77(2):336-340.

Iacob R, Manolescu D L, Stoicescu E R, et al. Breast Cancer-How Can Imaging Help?[J]. Healthcare (Basel), 2022,10(7).

Kakonen S M, Mundy G R. Mechanisms of osteolytic bone metastases in breast carcinoma[J]. Cancer, 2003,97(3 Suppl):834-839.

Johnson R W, Suva L J. Hallmarks of Bone Metastasis[J]. Calcif Tissue Int, 2018,102(2):141-151.

Yip R, Rimes J S, Capaldo B D, et al. Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis[J]. Nat Commun, 2021,12(1):6920.

Fornetti J, Welm A L, Stewart S A. Understanding the Bone in Cancer Metastasis[J]. J Bone Miner Res, 2018,33(12):2099-2113.

Mathis K M, Sturgeon K M, Winkels R M, et al. Bone resorption and bone metastasis risk[J]. Med Hypotheses, 2018,118:36-41.

Krzeszinski J Y, Wan Y. New therapeutic targets for cancer bone metastasis[J]. Trends Pharmacol Sci, 2015,36(6):360-373.

Choi S, Whitman M A, Shimpi A A, et al. Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer[J]. Nat Biomed Eng, 2023,7(11):1455-1472.

Perou C M, Sorlie T, Eisen M B, et al. Molecular portraits of human breast tumours[J]. Nature, 2000,406(6797):747-752.

Kennecke H, Yerushalmi R, Woods R, et al. Metastatic behavior of breast cancer subtypes[J]. J Clin Oncol, 2010,28(20):3271-3277.

Chao X, Zhang Y, Zheng C, et al. Metastasis of breast cancer to bones alters the tumor immune microenvironment[J]. Eur J Med Res, 2023,28(1):119.

Jiang Z, Song E, Geng C, et al. Chinese society of clinical oncology (CSCO) Breast Cancer Guidelines 2022[J]. Translational Breast Cancer Research, 2022,3:13.

DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i9.21172